Sumatriptan Injection, Solution
NDC Package 83270-156-06
Package Information
Sumatriptan injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache.Limitations of UseUse only if a clear diagnosis of migraine or cluster headache has been established. This formulation utilizes a injection, solution delivery system. Marketed by Onesource Specialty Pharma Limited, this product is identified by NDC 83270-156 and is authorized under FDA application ANDA090641.
Identification & Billing
- RxCUI: 313165 - SUMAtriptan 6 MG in 0.5 ML Injection
- RxCUI: 313165 - 0.5 ML sumatriptan 12 MG/ML Injection
- RxCUI: 313165 - sumatriptan (as sumatriptan succinate) 12 MG/ML Injection
- RxCUI: 313165 - sumatriptan 6 MG per 0.5 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83270 - Onesource Specialty Pharma Limited
- 83270-156 - Sumatriptan
- 83270-156-06 - 5 VIAL in 1 CARTON / .5 mL in 1 VIAL
- 83270-156 - Sumatriptan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83270-156-06 identifies a specific commercial package of 5 vial in 1 carton / .5 ml in 1 vial of Sumatriptan, a human prescription drug labeled by Onesource Specialty Pharma Limited. This injection, solution is formulated for subcutaneous use and contains sumatriptan succinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Onesource Specialty Pharma Limited on July 09, 2023. The current certification is valid through December 31, 2027.
How is this Onesource Specialty Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83270015606. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.